Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control (2020)
- Authors:
- USP affiliated authors: LEON, ELAINE PIRES - FM ; SILVA, CLOVIS ARTUR ALMEIDA DA - FM ; BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
- Unidade: FM
- DOI: 10.1007/s10067-020-04932-9
- Subjects: AUTOANTICORPOS; FÁRMACOS IMUNOSSUPRESSORES; VIMENTINA; ÍNDICE DE GRAVIDADE DA DOENÇA
- Agências de fomento:
- Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo [2009/51897-5, 2015/03756-4]
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303422/2015-7, 305068/2014-8]
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/51897-5, 2015/03756-4]
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical rheumatology
- ISSN: 0770-3198
- Volume/Número/Paginação/Ano: v. 39, n. 6, p. 1747-1755, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DINIS, Valquiria G et al. Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control. Clinical rheumatology, v. 39, n. 6, p. 1747-1755, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10067-020-04932-9. Acesso em: 13 fev. 2026. -
APA
Dinis, V. G., Viana, V. T., Leon, E. P., Silva, C. A. A. da, Saad, C. G., Moraes, J. C., et al. (2020). Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control. Clinical rheumatology, 39( 6), 1747-1755. doi:10.1007/s10067-020-04932-9 -
NLM
Dinis VG, Viana VT, Leon EP, Silva CAA da, Saad CG, Moraes JC, Bonfa ESD de O, Medeiros-ribeiro AC. Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control [Internet]. Clinical rheumatology. 2020 ; 39( 6): 1747-1755.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10067-020-04932-9 -
Vancouver
Dinis VG, Viana VT, Leon EP, Silva CAA da, Saad CG, Moraes JC, Bonfa ESD de O, Medeiros-ribeiro AC. Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control [Internet]. Clinical rheumatology. 2020 ; 39( 6): 1747-1755.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1007/s10067-020-04932-9 - Anti-adalimumab antibodies kinetics: an early guide for juvenile idiopathic arthritis (JIA) switching
- Is uric acid level a predictor of long-term renal outcome in lupus nephritis?
- Antibodies to cellular prion protein and its cognate ligand stress-inducible protein 1 in systemic lupus erythematosus
- Characterizing hand and wrist ultrasound pattern in primary Sjogren's syndrome: a case-control study
- Inactivated SARS-CoV-2 vaccine in primary Sjogren's syndrome: humoral response, safety, and effects on disease activity
- Lupus nephritis-related issues during COVID-19 pandemic quarantine
- Initial Benchmarking of the Quality of Medical Care in Childhood-Onset Systemic Lupus Erythematosus
- High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting
- Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country
- 23-valent polysaccharice pneumococcal vaccine in juvenile idiopathic arthritis patients: anti-tumor necrosis factor therapy role in short and long-term immunogenicity
Informações sobre o DOI: 10.1007/s10067-020-04932-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
